Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 4
iPTF discovery of iPTF15ayt, a young Type II Supernova showing flash-spectroscopy signatures, and an HST target
A. Gal-Yam, T. Petrushevska
Drugi članki ali sestavki
Oznake: supernovae;transient;
The intermediate Palomar Transient Factory (ATel#4807) reports the discovery of iPTF15ayt, a young type II SN in a nearby galaxy (redshift z=0.045715, mean distance modulus DM=36.52, metric distance d~202 Mpc; NED). The transient was discovered on 2015 May 26.32 UT at RA(J2000) = 14:56:27.85, DEC(J2 ...
Leto: 2015 Vir: Repozitorij Univerze v Novi Gorici (RUNG)
ǂA ǂpopulation of Type Ibc supernovae with massive progenitors
E. Karamehmetoglu, Jesper Sollerman, F. Taddia, C. Barbarino, U. Feindt, U. C. Fremling, A. Gal-Yam, M. M. Kasliwal, T. Petrushevska, S. Schulze
Izvirni znanstveni članek
Oznake: astronomy;supernova progenitors;
ǂA ǂpopulation of Type Ibc supernovae with massive progenitors
Leto: 2023 Vir: Repozitorij Univerze v Novi Gorici (RUNG)
ǂThe ǂPalomar Transient Factory core-collapse supernova host-galaxy sample
Steve Schulze, O. Yaron, Jesper Sollerman, G. Leloudas, Amit Gal, Angus H. Wright, Ragnhild Lunnan, A. Gal-Yam, Eran O. Ofek, T. Petrushevska
Izvirni znanstveni članek
Oznake: supernovae;galaxies;core-collapse supernovae;astronomy;
The Palomar Transient Factory core-collapse supernova host-galaxy sample
Leto: 2021 Vir: Repozitorij Univerze v Novi Gorici (RUNG)
Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy
Simona Borštnar, Marketa Palacova, Aleksandra Łacko, Constanta Timcheva, Einav Nili Gal-Yam, Konstantinos Papazisis, Juraj Beniak, Pavol Kudela, Gábor Rubovszky
Izvirni znanstveni članek
Oznake: CDK4/6 inhibitor;HER2−;HR+;advanced breast cancer;ribociclib;
The CDK4/6 inhibitor, ribociclib in combination with endocrine therapy significantly improved progression-free survival in the first line setting in post-menopausal patients with HR+/HER2- advanced breast cancer (ABC) in a pivotal phase 3, placebo-controlled trial (MONALEESA-2) and demonstrated supe ...
Leto: 2022 Vir: Onkološki inštitut Ljubljana (OI)
Št. zadetkov: 4
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: